Tendyne System as Possibility to Solve Mitral Incopmetence

MP067 

Abstract Submission 

Ales Mokracek (1), Ladislav Pesl (2), Julia Csanady (3), Vojtech Kurfirst (3), Mirek Sulda (3), Radim Frana (3)

(1) Nemocnice Ceske Budejovice, České Budějovice, (2) Hospital Ceske Budejovice, Ceske Budejovice, (3) Hospital Ceske Budejovice, Ceske Budejovice, NA

Ales Mokracek    -  Contact Me
Nemocnice Ceske Budejovice

Ladislav Pesl    -  Contact Me
Hospital Ceske Budejovice

Julia Csanady    -  Contact Me
Hospital Ceske Budejovice

Vojtech Kurfirst    -  Contact Me
Hospital Ceske Budejovice

Mirek Sulda    -  Contact Me
Hospital Ceske Budejovice

Radim Frana    -  Contact Me
Hospital Ceske Budejovice

Ales Mokracek    -  Contact Me
Nemocnice Ceske Budejovice

Objective: We sould like to present our initial experiences with Tendyne system for mitral valve replacement as alternative for some patients who are not suitable candidate for standard surgery.
Metods: Between 9/21 and 1/22 we implanted in 7 patients with sever native mitral insufficiency Tendyne system. System was implanted via left aneteroalateral minithoracotomy in touch of optimal position for implantation. Av age 76,7 (70-85) year. 2 had previous CABG. Risk of periprocedural mortality (STS risk score) for standard mitral valve replacement was 9,8%. All patients had dominant pathology Carpentier I aetiology. All patients were evaluated by specialist from Abbott to confirm technical conditions and probablity of success.
Results: In all patients we system implanted succesfuly and without complications. No conversion or reoperning for bleeding. No wound infection, ICU stay av.2,4 (1-7 days), all stay av.12 (8-20 days). In all patients was mitral insufficiency changed from heavy lto zero. The same result (still zero) we see in early postprocerula follow.. MG on the prostehsis is low, 3,07 torr at discharge.
Conclusions: Tendyne system seems to be very effective catheter based metod of treatment of native mitral insufficiency. Seems to be an alternative in high risk patients. We need more patients and longer follow up for stronger conclusions.

Mitral Valve Replacement